|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 5/14 | (2018.01) |
| C07D 215/56 | (2006.01) | ||
| C07F 7/08 | (2006.01) | ||
| A61P 3/06 | (2018.01) | ||
| A61K 31/695 | (2006.01) | ||
| A61P 21/02 | (2018.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61P 1/10 | (2018.01) | ||
| A61P 1/18 | (2018.01) | ||
| A61P 25/28 | (2018.01) | ||
| C07D 215/56 | (2013.01) | ||
| A61P 37/08 | (2018.01) | ||
| A61P 19/08 | (2018.01) | ||
| A61P 3/10 | (2018.01) | ||
| A61P 25/14 | (2018.01) | ||
| C07F 7/0812 | (2013.01) | ||
| A61P 11/06 | (2018.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 25/16 | (2018.01) | ||
| A61P 5/00 | (2018.01) | ||
| A61P 7/00 | (2018.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61K 31/695 | (2013.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 15/00 | (2018.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 11/02 | (2018.01) |
| (11) | Number of the document | 3440057 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17718318.3 |
| Date of filing the European patent application | 2017-04-07 | |
| (97) | Date of publication of the European application | 2019-02-13 |
| (45) | Date of publication and mention of the grant of the patent | 2021-09-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/026579 |
| Date | 2017-04-07 |
| (87) | Number | WO 2017/177124 |
| Date | 2017-10-12 |
| (30) | Number | Date | Country code |
| 201662319439 P | 2016-04-07 | US |
| (72) |
MUNOZ, Benito , US
PARKS, Daniel , US
BASTOS, Cecilia, M. , US
|
| (73) |
Proteostasis Therapeutics, Inc. ,
80 Guest Street, Suite 500, Boston, MA 02135,
US
|
| (54) | SILICONE ATOMS CONTAINING IVACAFTOR ANALOGUES |
| SILICONE ATOMS CONTAINING IVACAFTOR ANALOGUES |